Taysha Gene Therapies, Inc. TSHA Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Taysha Gene Therapies, Inc.’s reported figures.
The official record: Taysha Gene Therapies, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Taysha Gene Therapies, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Taysha Gene Therapies, Inc.'s invested capital?
- Taysha Gene Therapies, Inc. (TSHA) reported invested capital of $3.92M in Q1 2026.
- How has Taysha Gene Therapies, Inc.'s invested capital changed year-over-year?
- Taysha Gene Therapies, Inc.'s invested capital increased by 4025.3% year-over-year, from $95K to $3.92M.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s invested capital?
- Over 4 years (2021 to 2025), Taysha Gene Therapies, Inc.'s invested capital has grown at a -36.5% compound annual growth rate (CAGR), from -$16.53M to -$2.69M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).